You are here: Homepage Sectorfocus Life Sciences
Life Sciences
Meest recente
1 naar 10 van 425
-
Artikel
Ingediend: 17 December 2014
The case of Comau UK Limited v Lotus Lightweight Structures Limited (unreported) 27 June 2014 has established that contractual clauses allowing termination for convenience may limit compensation for breach of contract.
-
Artikel
Ingediend: 20 November 2014
What is expected to be an almost final version of the Rules of Procedure for the Unified Patent Court has been released.
-
Conferentiegesprek
Ingediend: 19 November 2014
Speakers from across the Simmons & Simmons network cover the key practical considerations arising in Competition Investigations; covering the conduct of internal investigations; handling Dawn Raids and information requests; the criminal cartel offence; immunity and leniency applications; and the co-ordination of multiple country, and multiple regulator, investigations.
-
Seminar
Ingediend: 17 November 2014
The emerging topic of Digital Health has great promise to reduce inefficiencies in healthcare delivery, reduce costs and make medicine more personalised and precise. This conference aimed to give an insight into opportunities for those looking to invest in digital health and to network with digital health innovators.
-
Artikel
Ingediend: 14 November 2014
Joint UK/German announcement concerning BEPS proposals to deal with preferential IP tax regimes puts continued existence of UK patent box and similar regimes in current form in doubt in medium term.
-
Artikel
Ingediend: 12 November 2014
MedTech Europe has announced that it proposes to phase out direct sponsorship of healthcare professionals at third party events by their members by 01 January 2018.
-
Video Podcast
Ingediend: 22 October 2014
Filippo Fioretti and Ombline Ancelin discuss the controversial Italian case finding a collusive strategy in the off label use of a medicine and the damages action it triggered.
-
Artikel
Ingediend: 20 October 2014
The case of AB v CD [2014] EWCA Civ 229 has established that damages may not be an adequate remedy if they are contractually limited or excluded.
-
Artikel
Ingediend: 16 October 2014
Outlines the EMA's clinical trial data publication policy and the management of potential associated risks.
-
Artikel
Ingediend: 14 October 2014
Simmons & Simmons responds to the consultation by DG Competition’s White Paper: towards more effective EU merger control?
1 naar 10 van 425